https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Double-blind placebo-controlled study of rifaximin and lactulose hydrogen breath test in Gulf War Veterans with irritable bowel syndrome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42447 P = 0.25) or QOL (all P = 0.26). Normalization of SIBO by LHBT was not different between rifaximin- and placebo-treated Veterans (7 vs. 22%, P = 0. 54). Conclusion: Rifaximin was not effective in improving IBS symptoms and QOL in GW Veterans with non-constipated IBS.]]> Tue 23 Aug 2022 11:08:19 AEST ]]> Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46015 0.5). Conclusions: In FD patients, the response to antimicrobial therapy with rifaximin is not influenced by concomitant IBS symptoms.]]> Tue 08 Nov 2022 18:38:07 AEDT ]]> Irritable bowel syndrome: rational therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13490 Sat 24 Mar 2018 08:16:45 AEDT ]]>